Chemoinformaics analysis of FLAVONOL-3-O-BETA-D-GLUCOSIDE
| Molecular Weight | 400.383 | nRot | 4 |
| Heavy Atom Molecular Weight | 380.223 | nRig | 24 |
| Exact Molecular Weight | 400.116 | nRing | 4 |
| Solubility: LogS | -3.431 | nHRing | 2 |
| Solubility: LogP | 1.198 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 2 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 17 |
| nHA | 8 | APOL | 54.8219 |
| nHD | 4 | BPOL | 26.1401 |
| QED | 0.502 |
| Synth | 3.483 |
| Natural Product Likeliness | 1.509 |
| NR-PPAR-gamma | 0.536 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.178 |
| Pgp-sub | 0.014 |
| HIA | 0.268 |
| CACO-2 | -5.393 |
| MDCK | 0.0000476 |
| BBB | 0.521 |
| PPB | 0.83139 |
| VDSS | 0.95 |
| FU | 0.130678 |
| CYP1A2-inh | 0.071 |
| CYP1A2-sub | 0.052 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.082 |
| CYP2c9-inh | 0.009 |
| CYP2c9-sub | 0.277 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.237 |
| CYP3a4-inh | 0.003 |
| CYP3a4-sub | 0.093 |
| CL | 1.445 |
| T12 | 0.31 |
| hERG | 0.01 |
| Ames | 0.529 |
| ROA | 0.043 |
| SkinSen | 0.048 |
| Carcinogencity | 0.507 |
| EI | 0.011 |
| Respiratory | 0.019 |
| NR-Aromatase | 0.913 |
| Antiviral | Yes |
| Prediction | 0.817926 |